Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $1,954 | 80 | 99.6% |
| Education | $8.45 | 1 | 0.4% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Amgen Inc. | $813.04 | 55 | $0 (2024) |
| ABBVIE INC. | $514.97 | 9 | $0 (2024) |
| Celgene Corporation | $384.87 | 9 | $0 (2019) |
| PFIZER INC. | $91.96 | 2 | $0 (2023) |
| Lilly USA, LLC | $74.80 | 2 | $0 (2022) |
| Galderma Laboratories, L.P. | $44.69 | 1 | $0 (2020) |
| Sun Pharmaceutical Industries Inc. | $27.97 | 2 | $0 (2019) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $320.79 | 7 | ABBVIE INC. ($221.22) |
| 2023 | $324.66 | 15 | AbbVie Inc. ($156.74) |
| 2022 | $174.31 | 12 | Amgen Inc. ($155.84) |
| 2021 | $275.23 | 22 | Amgen Inc. ($275.23) |
| 2020 | $255.43 | 10 | Amgen Inc. ($134.82) |
| 2019 | $194.45 | 6 | Celgene Corporation ($95.69) |
| 2018 | $315.32 | 7 | Celgene Corporation ($187.37) |
| 2017 | $101.81 | 2 | Celgene Corporation ($101.81) |
All Payment Transactions
81 individual payment records from CMS Open Payments — Page 1 of 4
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/09/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $30.02 | General |
| Category: IMMUNOLOGY | ||||||
| 10/10/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $75.47 | General |
| Category: IMMUNOLOGY | ||||||
| 08/27/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $6.66 | General |
| Category: IMMUNOLOGY | ||||||
| 04/25/2024 | Amgen Inc. | Otezla (Drug) | Food and Beverage | In-kind items and services | $18.83 | General |
| Category: Inflammation | ||||||
| 04/09/2024 | Amgen Inc. | Otezla (Drug) | Food and Beverage | In-kind items and services | $80.74 | General |
| Category: Inflammation | ||||||
| 03/20/2024 | ABBVIE INC. | — | Education | In-kind items and services | $8.45 | General |
| 03/19/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $100.62 | General |
| Category: IMMUNOLOGY | ||||||
| 12/14/2023 | Amgen Inc. | Otezla (Drug) | Food and Beverage | In-kind items and services | $4.41 | General |
| Category: Inflammation | ||||||
| 11/16/2023 | Amgen Inc. | Otezla (Drug) | Food and Beverage | In-kind items and services | $70.39 | General |
| Category: Inflammation | ||||||
| 11/16/2023 | Amgen Inc. | Otezla (Drug) | Food and Beverage | In-kind items and services | $4.60 | General |
| Category: Inflammation | ||||||
| 10/26/2023 | AbbVie Inc. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $77.70 | General |
| Category: IMMUNOLOGY | ||||||
| 10/19/2023 | Amgen Inc. | Otezla (Drug) | Food and Beverage | In-kind items and services | $9.07 | General |
| Category: Inflammation | ||||||
| 09/14/2023 | Amgen Inc. | Otezla (Drug) | Food and Beverage | In-kind items and services | $3.20 | General |
| Category: Inflammation | ||||||
| 08/01/2023 | Amgen Inc. | Otezla (Drug) | Food and Beverage | In-kind items and services | $3.99 | General |
| Category: Inflammation | ||||||
| 05/25/2023 | Amgen Inc. | Otezla (Drug) | Food and Beverage | In-kind items and services | $4.65 | General |
| Category: Inflammation | ||||||
| 04/20/2023 | Amgen Inc. | Otezla (Drug) | Food and Beverage | In-kind items and services | $2.80 | General |
| Category: Inflammation | ||||||
| 04/06/2023 | Amgen Inc. | Otezla (Drug) | Food and Beverage | In-kind items and services | $5.65 | General |
| Category: Inflammation | ||||||
| 03/23/2023 | PFIZER INC. | CIBINQO (Drug), COMIRNATY, PAXLOVID | Food and Beverage | In-kind items and services | $20.34 | General |
| Category: Inflammation & Immunology | ||||||
| 03/16/2023 | Amgen Inc. | Otezla (Drug) | Food and Beverage | In-kind items and services | $17.86 | General |
| Category: Inflammation | ||||||
| 02/02/2023 | Amgen Inc. | Otezla (Drug) | Food and Beverage | In-kind items and services | $15.66 | General |
| Category: Inflammation | ||||||
| 01/18/2023 | AbbVie Inc. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $79.04 | General |
| Category: IMMUNOLOGY | ||||||
| 01/09/2023 | Amgen Inc. | Otezla (Drug) | Food and Beverage | In-kind items and services | $5.30 | General |
| Category: Inflammation | ||||||
| 10/27/2022 | Amgen Inc. | Otezla (Drug) | Food and Beverage | In-kind items and services | $15.99 | General |
| Category: Inflammation | ||||||
| 09/30/2022 | Amgen Inc. | Otezla (Drug) | Food and Beverage | In-kind items and services | $4.18 | General |
| Category: Inflammation | ||||||
| 09/15/2022 | Lilly USA, LLC | TALTZ (Drug), OLUMIANT | Food and Beverage | In-kind items and services | $18.47 | General |
| Category: Immunology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 17 | 1,510 | 2,490 | $562,457 | $73,763 |
| 2022 | 15 | 1,614 | 2,506 | $515,551 | $66,312 |
| 2021 | 20 | 1,892 | 2,985 | $633,955 | $86,110 |
| 2020 | 16 | 1,764 | 2,888 | $578,331 | $69,576 |
All Medicare Procedures & Services
68 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2023 | 233 | 295 | $74,673 | $20,146 | 27.0% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Facility | 2023 | 303 | 381 | $63,494 | $17,254 | 27.2% |
| 17000 | Destruction of precancer skin growth, 1 growth | Facility | 2023 | 215 | 308 | $110,701 | $10,550 | 9.5% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Facility | 2023 | 57 | 57 | $22,487 | $5,591 | 24.9% |
| 17262 | Destruction of cancer skin growth of trunk, arms, or legs, 1.1-2.0 cm | Facility | 2023 | 34 | 49 | $46,085 | $3,730 | 8.1% |
| 11102 | Biopsy of related skin growth, first growth | Facility | 2023 | 137 | 160 | $85,800 | $3,238 | 3.8% |
| 17110 | Destruction of skin growth, 1-14 growths | Facility | 2023 | 64 | 69 | $41,141 | $3,024 | 7.3% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Facility | 2023 | 123 | 142 | $16,600 | $3,001 | 18.1% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Facility | 2023 | 57 | 57 | $15,292 | $2,687 | 17.6% |
| 11103 | Biopsy of related skin growth, each additional growth | Facility | 2023 | 46 | 80 | $23,112 | $1,289 | 5.6% |
| 17003 | Destruction of precancer skin growth, 2-14 growths | Facility | 2023 | 157 | 806 | $24,244 | $1,149 | 4.7% |
| 99202 | New patient office or other outpatient visit, 15-29 minutes | Facility | 2023 | 17 | 17 | $3,309 | $548.40 | 16.6% |
| 11104 | Punch biopsy, first skin growth | Facility | 2023 | 14 | 15 | $10,114 | $441.25 | 4.4% |
| 99451 | Telephone, internet, or electronic health record assessment and management with written report by consulting physician, at least 5 minutes | Facility | 2023 | 14 | 14 | $2,089 | $355.94 | 17.0% |
| 11310 | Shaving of skin growth of face, ears, eyelids, nose, lips, or mouth, 0.5 cm or less | Facility | 2023 | 11 | 11 | $6,699 | $275.84 | 4.1% |
| 11301 | Shaving of skin growth of body, arms, or legs, 0.6-1.0 cm | Facility | 2023 | 11 | 12 | $7,731 | $251.86 | 3.3% |
| 11300 | Shaving of skin growth of body, arms, or legs, 0.5 cm or less | Facility | 2023 | 17 | 17 | $8,887 | $231.30 | 2.6% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2022 | 220 | 256 | $60,557 | $15,608 | 25.8% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Facility | 2022 | 321 | 362 | $56,392 | $14,595 | 25.9% |
| 17000 | Destruction of precancer skin growth, 1 growth | Facility | 2022 | 251 | 313 | $105,027 | $10,107 | 9.6% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Facility | 2022 | 54 | 54 | $19,902 | $4,349 | 21.9% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Facility | 2022 | 150 | 159 | $17,328 | $3,857 | 22.3% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Facility | 2022 | 66 | 66 | $16,548 | $3,825 | 23.1% |
| 11102 | Biopsy of related skin growth, first growth | Facility | 2022 | 152 | 172 | $86,172 | $3,292 | 3.8% |
| 17110 | Destruction of skin growth, 1-14 growths | Facility | 2022 | 71 | 81 | $45,137 | $3,086 | 6.8% |
About Lawrence Scherrer, MD PHD
Lawrence Scherrer, MD PHD is a Dermatology healthcare provider based in Eau Claire, Wisconsin. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 10/19/2006. The National Provider Identifier (NPI) number assigned to this provider is 1790867968.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Lawrence Scherrer, MD PHD has received a total of $1,962 in payments from pharmaceutical and medical device companies, with $320.79 received in 2024. These payments were reported across 81 transactions from 8 companies. The most common payment nature is "Food and Beverage" ($1,954).
As a Medicare-enrolled provider, Scherrer has provided services to 6,780 Medicare beneficiaries, totaling 10,869 services with total Medicare billing of $295,761. Data is available for 4 years (2020–2023), covering 68 distinct procedure/service records.
Practice Information
- Specialty Dermatology
- Location Eau Claire, WI
- Active Since 10/19/2006
- Last Updated 07/08/2007
- Taxonomy Code 207N00000X
- Entity Type Individual
- NPI Number 1790867968
Products in Payments
- Otezla (Drug) $1,162
- SKYRIZI (Biological) $254.24
- RINVOQ (Biological) $191.19
- TALTZ (Drug) $74.80
- EUCRISA (Drug) $71.62
- Humira (Biological) $61.09
- AKLIEF (Drug) $44.69
- ILUMYA (Biological) $27.97
- CIBINQO (Drug) $20.34
- Enbrel (Biological) $7.00
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Dermatology Doctors in Eau Claire
Dr. Stephanie Tadayon, Md, MD
Dermatology — Payments: $963.76
Christine Murphy, Md, MD
Dermatology — Payments: $649.60
Elizabeth Demaree, Do, DO
Dermatology — Payments: $539.35
Mary Lou Ernst-Woodhouse, Do, DO
Dermatology — Payments: $195.30
Daniel Jones, Md, MD
Dermatology — Payments: $108.48
Patrice Hicks, Md, MD
Dermatology — Payments: $99.99